{
  "actions": [
    {
      "acted_at": "2018-09-27",
      "action_code": "10000",
      "references": [],
      "text": "Introduced in Senate",
      "type": "action"
    },
    {
      "acted_at": "2018-09-27",
      "action_code": "",
      "committees": [
        "SSHR"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Read twice and referred to the Committee on Health, Education, Labor, and Pensions.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "s3519-115",
  "bill_type": "s",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "Senate Health, Education, Labor, and Pensions",
      "committee_id": "SSHR"
    }
  ],
  "congress": "115",
  "cosponsors": [
    {
      "bioguide_id": "B001267",
      "district": null,
      "name": "Bennet, Michael F.",
      "original_cosponsor": true,
      "sponsored_at": "2018-09-27",
      "state": "CO",
      "title": "Sen.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2018-09-27",
  "number": "3519",
  "official_title": "A bill to establish a process for the Food and Drug Administration to determine whether to modify the labeling of drugs whose labeling may be outdated, including drugs with accepted uses that are not reflected in the approved labeling.",
  "popular_title": null,
  "related_bills": [],
  "short_title": "Making Objective Drug Evidence Revisions for New Labeling Act",
  "sponsor": {
    "bioguide_id": "H000338",
    "district": null,
    "name": "Hatch, Orrin G.",
    "state": "UT",
    "title": "Sen.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2018-09-27",
  "subjects": [
    "Health"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in Senate",
    "asOf": "2018-09-27",
    "date": "2019-08-20T20:35:00Z",
    "text": "Making Objective Drug Evidence Revisions for New Labeling Act or the MODERN Labeling Act\n\nThis bill amends the Federal Food, Drug, and Cosmetic Act to provide the Food and Drug Administration with authority to require updates to drug labeling to reflect new information relevant to the drug and its use."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "MODERN Labeling Act",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "A bill to establish a process for the Food and Drug Administration to determine whether to modify the labeling of drugs whose labeling may be outdated, including drugs with accepted uses that are not reflected in the approved labeling.",
      "type": "official"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Making Objective Drug Evidence Revisions for New Labeling Act",
      "type": "short"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "MODERN Labeling Act",
      "type": "short"
    }
  ],
  "updated_at": "2023-01-11T13:41:18Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/115/s/BILLSTATUS-115s3519.xml"
}